Toremifene
- TRADE NAME: Fareston (ProStrakan)
- INDICATIONS: Metastatic breast cancer
- CLASS: Selective estrogen receptor modulator (SERM)
- HALF-LIFE: ~5 days
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amoxapine, Arsenic, Dolasetron, Efavirenz, Pazopanib, Sugammadex, Telavancin
PREGNANCY CATEGORY: D
QT PROLONGATION
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric